Modelling

• FC 13-01 • Compressed compartmental multi-type HPV models- Can they be used to inform cervical cancer screening? See abstract > S. S. VÄNSKÄ • FC 13-02 • The cost-effectiveness of national HPV immunization programmes in six European tender-based settings See abstract > V. Venetia QENDRI • FC 13-03 • Cost-effectiveness of expanding the HPV vaccination program to include preadolescent boys in Sweden See abstract > E. E. WOLFF • FC 13-04 • Optimal improvements to cervical cancer prevention: example from Australia See abstract > M. Megan SMITH • FC 13-05 • Public health and economic impact of gender neutral vaccination program with a nine-valent HPV vaccine in Sweden See abstract > E. E. MORAIS • FC 13-06 • New evidence with regard to test characteristics from a modelling study See abstract > E. E. JANSEN • FC 13-07 • Health and economic impact of HPV testing compared to cytology: what is the optimal primary cervical cancer screening strategy for Canada ? See abstract > J. J.F. LAPRISE • FC 13-08 • Health-related quality of life in the prevention, screening and management of cervical disease: a systematic review See abstract > A. A. Ó CÉILLEACHAIR • FC 13-09 • Clinical & cost-effectiveness of HPV primary screening & dual-stain cytology in Thailand See abstract > W. W. TERMRUNGRUANGLERT • FC 13-10 • Cost analysis of Human Papillomavirus related cervical diseases and genital warts in Swaziland See abstract > T. Themba GININDZA